2026-04-29T00:59:49Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/228132024-11-28T22:09:49Zcom_20.500.12105_15322com_20.500.12105_2051col_20.500.12105_16967col_20.500.12105_16981

00925njm 22002777a 4500 dc Vera, R author Aparicio, J author Carballo, F author Esteva, Magdalena author Gonzalez-Flores, E author Santianes, J author Santolaya, F author Fernandez-Cebrian, JM author 2019-10 Colorectal cancer (CRC) is one of the tumours with the highest incidence and mortality in the Spanish population. Nevertheless, the advances in prevention and treatment have contributed to an increased number of patients who survive for prolonged periods of time. In addition, despite recurrences, improved survival following metastasis resection is likewise on the rise. This underscores the importance of carrying out follow-up programmes even in low-risk patients for the early detection of recurrence. The main objective of this article is to provide a set of recommendations for optimising the follow-up of CRC survivors as well as for managing the sequelae that result from either pharmacological or surgical treatment. Vera R, Aparicio J, Carballo F, Esteva M, Gonzalez-Flores E, Santianes J, et al. Recommendations for follow-up of colorectal cancer survivors. Clin Transl Oncol. 2019 Oct;21(10):1302-11. Epub 2019 Feb 14. 1699-048X http://hdl.handle.net/20.500.13003/14687 https://hdl.handle.net/20.500.12105/22813 30762206 10.1007/s12094-019-02059-1 1699-3055 Clinical & Translational Oncology 2-s2.0-85061628879 486535700002 L626412990 Cancer survivors Treatment sequelae Quality of life Surveillance Monitoring Care coordination Recommendations for follow-up of colorectal cancer survivors